AZYRADA

Serial Number 90739249
721

Registration Progress

Application Filed
May 27, 2021
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered

Trademark Image

AZYRADA

Basic Information

Serial Number
90739249
Filing Date
May 27, 2021
Published for Opposition
March 22, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
721
Status Date
Apr 25, 2024
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-219

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Richard A. Friedman

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

27 events
Date Code Type Description Documents
Apr 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 25, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 4, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 4, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 4, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 13, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 13, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 13, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 28, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 28, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 28, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 17, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 17, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 12, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 3, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 23, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 31, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-inflammatory preparations; Pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis

Classification

International Classes
005